Replikins, Ltd. published a FluForecast� warning in April 7th, 2008, a year before the recent Mexico and California H1N1 cases. The company was able to state the likelihood of H1N1 outbreaks based on its patented Replikin Count™ genomics technology, which examines specific regions in virus genes which have been linked with past epidemics.The April 2008 announcement, attached below as published on the Web, stated that in H1N1 the company had then detected the highest concentrations of these specific regions ever seen, except for those from the 1918 pandemic which killed millions of people. Today, the company is actively pursuing licensing partnerships to apply its groundbreaking technology not only to early warning systems, but also to the development of synthetic vaccines to prevent or slow future epidemics. A synthetic H1N1 Replikins Vaccine is available for testing, and related products are described below and on the company's website. (PRWeb Apr 25, 2009)
Read the full story at http://www.prweb.com/releases/2009/04/prweb2360154.htm
Read More...
[Source: PRWeb: Lifestyle Travel and Tourism]
No comments:
Post a Comment